In a Facebook post on Friday, Health Minister Ong Ye Kung said Singapore's Expert Committee on COVID-19 Vaccination was reviewing data on the vaccine and would give recommendations soon.
Stocks should arrive by end-October, he added, noting that the updated vaccine - unlike a previous bivalent one - does not target the original strain of the coronavirus, which is no longer circulating widely in the community. HSA said that in reviewing - and ultimately approving - the updated vaccine, it considered data accrued from previous versions of Comirnaty shots, as well as information showing that it could enhance immune responses against the newly predominant Omicron subvariants.
The authority said it would monitor and review the evolving data on effectiveness and safety, to ensure the benefits of the vaccine continue to outweigh the known risks., also designed to target currently circulating Omicron subvariants.